Covered recipient · General Payments record
MAX P ROSEN
Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology
General Payments · PY2018–2024
$253,058.35
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $35,420.00 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AstraZeneca UK Limited | $35,420.00 | 12 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca UK Limited | $3,940.00 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093928863 | CMS |
| AstraZeneca UK Limited | $2,420.00 | 02/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094037964 | CMS |
| AstraZeneca UK Limited | $1,160.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093985479 | CMS |
| AstraZeneca UK Limited | $7,740.00 | 04/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093939126 | CMS |
| AstraZeneca UK Limited | $3,580.00 | 05/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094000559 | CMS |
| AstraZeneca UK Limited | $1,000.00 | 06/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094020591 | CMS |
| AstraZeneca UK Limited | $5,020.00 | 07/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093988669 | CMS |
| AstraZeneca UK Limited | $2,080.00 | 08/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094002865 | CMS |
| AstraZeneca UK Limited | $1,100.00 | 09/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093921170 | CMS |
| AstraZeneca UK Limited | $4,600.00 | 11/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093989775 | CMS |
| AstraZeneca UK Limited | $1,560.00 | 12/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093907030 | CMS |
| AstraZeneca UK Limited | $1,220.00 | 12/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093904736 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.